Not Tagged
vivace therapeutics
['mesothelioma']
aacr: vivace reports proof of concept for yap-tead inhibitor in #mesothelioma vivace therapeutics has presented what it said was the first proof of concept clinical data for a #cancer drug targeting the hippo-yap pathway at #aacr23. learn more: 
Serving the biotech industry since 1981. EIC @johnsterling4; publisher @liebertpub -- Subscribe to GEN: https://t.co/hANhLX7wxH